Results 101 to 110 of about 47,486 (163)

Blood Coagulation in COVID-19: Systems-Biology Evidence, Clinical Implications, and Therapeutic Opportunities in an Evolving Pandemic. [PDF]

ACS Omega
Hajjo R, Kharmah R.
europepmc   +1 more source

Allele-selective disruption of pathogenic VWF variants in type 2 von Willebrand disease using CRISPR/Cas9. [PDF]

Blood Adv
Bär I, Groten SA, Barraclough A, Bürgisser PE, van Kwawegen C, Lenting PJ, van Moort I, Eikenboom JCJ, Leebeek FWG, Voorberg J, van den Biggelaar M, Bierings R.   +11 more
europepmc   +1 more source

Toward improved thrombolysis in ischemic stroke: targeting nonfibrin components. [PDF]

Res Pract Thromb Haemost
De Meyer SF.
europepmc   +1 more source

Shaping hemophilia care: lessons and legacy of the SIPPET trial after 10 years. [PDF]

Res Pract Thromb Haemost
Peyvandi F, Palla R, Garagiola I, Mannucci PM.   +3 more
europepmc   +1 more source

Von Willebrand Factor and ADAMTS13 in Relation to Major Adverse Limb Events in Peripheral Artery Disease. [PDF]

Vasc Specialist Int
Agid N, Andrisani P, Khan H, Qadura M, Kretz CA, Bhagirath VC.   +5 more
europepmc   +1 more source

A NAC for Reducing vWF

The Hematologist, 2011
openaire   +1 more source

DNA methylation is associated with von Willebrand factor and coagulation factor VIII plasma levels: the atherosclerosis risk in communities study. [PDF]

Clin Epigenetics
Hahn J, Bressler J, Fornage M, Boerwinkle E, Smith NL, Morrison AC, de Vries PS.   +6 more
europepmc   +1 more source

Postpartum Acquired Hemophilia A in Two Women With Previously Undiagnosed Carrier Status for von Willebrand Disease Type 2N and Heterozygous p.R854Q Mutation. [PDF]

Haemophilia
Weise M, Klöter T, Keller M, Petros S, Pfrepper C.   +4 more
europepmc   +1 more source